| IGSF8 |
|---|
|
| Identifiers |
|---|
| Aliases | IGSF8, CD316, CD81P3, EWI-2, EWI2, KCT-4, LIR-D1, PGRL, immunoglobulin superfamily member 8 |
|---|
| External IDs | OMIM: 606644; MGI: 2154090; HomoloGene: 14163; GeneCards: IGSF8; OMA:IGSF8 - orthologs |
|---|
|
| Gene location (Mouse) |
|---|
| | Chr. | Chromosome 1 (mouse) |
|---|
| | Band | 1 H3|1 79.59 cM | Start | 172,089,208 bp |
|---|
| End | 172,147,408 bp |
|---|
|
| RNA expression pattern |
|---|
| Bgee | | Human | Mouse (ortholog) |
|---|
| Top expressed in | - right hemisphere of cerebellum
- right frontal lobe
- Brodmann area 9
- C1 segment
- prefrontal cortex
- cingulate gyrus
- anterior cingulate cortex
- putamen
- Hypothalamus
- nucleus accumbens
|
| | Top expressed in | - ventricular zone
- primary visual cortex
- superior frontal gyrus
- dorsomedial hypothalamic nucleus
- dentate gyrus of hippocampal formation granule cell
- subiculum
- perirhinal cortex
- superior colliculus
- respiratory epithelium
- nasal epithelium
|
| | More reference expression data |
|
|---|
| BioGPS | |
|---|
|
|
|
| Wikidata |
|
Immunoglobulin superfamily member 8 is a protein that in humans is encoded by the IGSF8 gene. IGSF8 has also been designated as CD316 (cluster of differentiation 316). IGSF8 is an innate immune checkpoint that inhibits the cytotoxic activity of natural killer (NK) cells. IGSF8 acts by binding to the Killer Ig-like Receptor KIR3DL2 (or, in mice, the analogous Klra9 receptor). IGSF8 is frequently overexpressed relative to normal tissues in many cancers, included melanoma, urothelial carcinoma, and breast cancer, and has been proposed as a potential therapeutic target in gliomas. In normal tissues, IGSF8 is highly expressed in the brain, where it may contribute to the immune privilege of the central nervous system.